Ilepatril TFA
Ilepatril TFA is a dual inhibitor of angiotensin-converting enzyme (ACE) and neutral endopeptidase (NEP), exhibiting physiological effects such as enhanced natriuresis and vasodilation. In animal studies and early clinical trials, Ilepatril TFA has demonstrated the ability to improve insulin sensitivity and metabolic abnormalities, suggesting its potential value in the treatment of cardiovascular and metabolic diseases.
Product Specifications
Purity
99.74% (May vary between batches)
Smiles
C ([C@@H]1CCC[C@@H]2C3C=CC=CC=3C[C@@H] (C (N12) =O) NC (=O) [C@H] (C (C) C) SC (=O) C) (=O) O.C (=O) (O) C (F) (F) F
Molecular Formula
C24H29F3N2O7S
Molecular Weight
546.56
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6392784-01 0.1 mL
RING Finger Protein 8 (RNF8, E3 Ubiquitin-protein Ligase RNF8, hRNF8, KIAA0646) (Biotin)
Sign In for Pricing
View Details MBS6392784-02 5x 0.1 mL
RING Finger Protein 8 (RNF8, E3 Ubiquitin-protein Ligase RNF8, hRNF8, KIAA0646) (Biotin)
Sign In for Pricing
View Details 
MBS7094306 Inquire
Recombinant Human Olfactory receptor 4C5 (OR4C5), partial
Sign In for Pricing
View Details GTR15379888 1 Vial
Lentiviral human ARRDC5 sgRNA gene knockout kit - Lentiviral human ARRDC5 sgRNA gene knockout kit (100)
Sign In for Pricing
View Details 